Gallano, Jun Mark .
HRN: 26-48-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2025
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
01/08/2025
01/15/2025
PO
1.5 Ml
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes